Gender differences in molecular‐guided therapy recommendations for metastatic malignant mesothelioma

BACKGROUND: Malignant mesothelioma is an aggressive cancer and has a poor prognosis. Here, we analyzed the feasibility, molecular and gender aspects of targeted therapy recommendations for malignant mesothelioma based on the individual molecular tumor profile. METHODS: In this single‐center, real‐wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Taghizadeh, Hossein, Zöchbauer‐Müller, Sabine, Mader, Robert M., Müllauer, Leonhard, Klikovits, Thomas, Bachleitner‐Hofmann, Thomas, Hoda, Mir A., Prager, Gerald W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327667/
https://www.ncbi.nlm.nih.gov/pubmed/32438515
http://dx.doi.org/10.1111/1759-7714.13491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327667/
https://www.ncbi.nlm.nih.gov/pubmed/32438515
http://dx.doi.org/10.1111/1759-7714.13491

Ejemplares similares